Balance After Cancer - Is it Even Possible? (Part 1 of 2)

Patient Info: Anonymized, Male, 70+ | Stage III

At age 72, the patient was 5 years beyond lung surgery, breathing normally with one lung and described as in remission. A separate 2-year history of prostate cancer was asymptomatic and also described as in remission.

Stage IV Lung Cancer: Michael's Patient Story

Patient Info: Michael O’Donnell, Male | Stage IV

More than 5 years after a Stage IV diagnosis, Michael remained on immunotherapy with disease controlled to his and his doctor’s satisfaction and scans every 3 months to watch for growth.

Stage IV EGFR Lung Cancer: Marnie's Patient Story

Patient Info: Marnie Clark, Female | Stage IV

Biomarkers: EGFR-positive

Metastatic Site: brain

Two years after diagnosis, Marnie reported that the brain tumor was gone, her leg was almost back to normal, and her first targeted medication continued to control the lung cancer.

We're Back! Q&A With Breathe Deep TOGETHER Team Captains — Case 2

Patient Info: Anonymized | Stage I

This patient reported being 13 years cancer-free after Stage I lung cancer, while still experiencing recurrence anxiety around follow-up visits.

Lung Cancer: Xavier's Patient Story

Patient Info: Xavier Sanders, Male | Stage Metastatic/Advanced

Metastatic Site: kidneys

Xavier’s lung disease had cleared, but cancer in his kidneys remained under treatment with 2 pills daily and checkups every 3 months; he reported major improvement in his mental health after seeking help.

Stage I Non-Small Cell Lung Cancer: Robert's Survivor Story

Patient Info: Robert Tumanic, Male | Stage I

After SBRT, follow-up scans showed the treated tumors resolved and no additional tumors requiring treatment; as of May 2019, the treated sites were stable and no further lung-cancer therapy was required.

Lung Cancer: François's Survivor Story

Patient Info: François, Male, 60s

François completed 20 radiation sessions and 6 chemotherapy sessions for lung cancer diagnosed in 2010 and later continued routine hospital checks every 6 months.

Lung Cancer: Katia's Survivor Story

Patient Info: Katia, Female, 40s

Katia had a cancerous lung nodule removed with partial left lung surgery in January 2015 and continued yearly imaging surveillance afterward.

Small Cell Lung Cancer: François's Patient Story

Patient Info: François, Male, 60s

Françoise described supporting her husband François through small cell lung cancer and returning each year for hospital monitoring with CT and MRI scans.

Non-Small Cell Lung Cancer: Jode's Patient Story

Patient Info: Jode, Male

Jode’s husband had non-small cell lung cancer diagnosed in 2010, received 33 chemotherapy cycles over 1 year, and later continued 6-monthly oncology and pulmonology follow-up.

Lung Cancer: Julie's Survivor Story

Patient Info: Julie, Female, 70+

Julie had early-stage localized lung cancer without metastases, underwent right upper-lobe lobectomy and 6 chemotherapy treatments, and was told in October 2017 that she was in complete remission.

Stage IV Lung Cancer: Thierry's Survivor Story

Patient Info: Thierry, Male, 50s | Stage IV

Metastatic Site: Brain

Thierry had lung cancer with a brain metastasis treated with urgent brain surgery, radiotherapy, chemotherapy, and lung tumor surgery; later he lived under close surveillance after seizures and treatment-related recovery.

EGFR Lung Cancer: Caroline's Patient Story

Patient Info: Caroline, Female

Biomarkers: Germline EGFR T790M mutation

Ongoing surveillance for germline EGFR T790M-associated lung nodules / lung cancer risk after October 2022 surgery and complications; the story does not support Stage IV disease for Caroline.

Lung Cancer Research FoundationRead more →

Stage IV ALK Non-Small Cell Lung Cancer: Marley's Patient Story

Patient Info: Marley, Female | Stage IV

Biomarkers: ALK-positive

Metastatic Site: Chest lymph nodes; axillary lymph nodes; lymph nodes…

Living with Stage IV ALK-positive NSCLC involving lymph nodes and malignant pleural fluid, with scans every 3 months; specific treatment regimen is not reported.

Lung Cancer Research FoundationRead more →

Stage I EGFR Lung Adenocarcinoma: Julie's Patient Story

Patient Info: Julie, Female, 40s | Stage I

Biomarkers: EGFR exon 19 deletion

Ongoing care after Stage IB EGFR exon 19 lung adenocarcinoma treated with lower left lobectomy and Tagrisso/osimertinib, with CT and MRI surveillance; no recurrence/NED statement is explicitly provided.

Lung Cancer Research FoundationRead more →

Stage IV ALK Non-Small Cell Lung Cancer: Duane's Patient Story

Patient Info: Duane Steiner, Male, 50s | Stage IV

Biomarkers: ALK-positive / ALK gene mutation identified by molecular or genomic testing

Living more than 6 years with incurable Stage IV ALK-positive lung cancer, supported by targeted therapy, clinical-trial participation, Hope Lodge access, and periodic monitoring.

EGFR Non-Small Cell Lung Cancer: Donna's Patient Story

Patient Info: Donna Thompson, Female, 40s

Biomarkers: EGFR-positive lung cancer reported during recurrence; initial tumor biomarker status not reported

Recurrent NSCLC after earlier Stage II surgery and limited chemotherapy; later EGFR-targeted therapy caused kidney failure, 2 new spots were radiated in July 2025, and new nodules are under watchful monitoring.

GO2 FoundationRead more →

Stage IV Non-Small Cell Lung Cancer: Usha's Patient Story

Patient Info: Usha Jain, Female | Stage IV

Biomarkers: Tumor genetic profile available for navigation review, but specific results are not reported

Stage IV NSCLC after nearly 2 years of chemotherapy and immunotherapy, followed by watchful monitoring with routine scans; clinical trials were reviewed but not pursued.

GO2 FoundationRead more →

Stage IV HER2-Positive Non-Small Cell Lung Cancer: Glenna's Survivor Story

Patient Info: Glenna, Female | Stage IV

Biomarkers: HER2 mutation confirmed by blood and tissue biopsy biomarker testing

Stage IV HER2-mutated NSCLC with first-line chemotherapy failure, then ongoing Enhertu from September 2023 and official NED/no evidence of disease status.

Lung Cancer Research FoundationRead more →

Stage III EGFR Non-Small Cell Lung Cancer: Lauren's Survivor Story

Patient Info: Lauren, Female, Under 40 | Stage III

Biomarkers: EGFR mutation

No evidence of cancer on 1-year scan after fertility preservation, chemotherapy, radiation, and removal of half the left lung for Stage III EGFR-mutated lung cancer.

Lung Cancer Research FoundationRead more →

Stage III Lung Adenocarcinoma: Becky's Survivor Story

Patient Info: Becky Manning, Female, 40s | Stage III

After surgery, chemotherapy and 8 months of nivolumab on a clinical trial, Becky was no longer on active treatment, had no evidence of disease, felt well, and returned to MSK every 6 months for follow-up.

Memorial Sloan KetteringRead more →

Stage III Non-Small Cell Lung Cancer: Heidi's Survivor Story

Patient Info: Heidi N., Female, 50s | Stage III

Biomarkers: No targetable mutation identified

As of June 2026, Heidi was featured as a lung cancer advocate after treatment for inoperable Stage IIIA NSCLC; scans through January 2021 had shown no evidence of disease.

The Patient StoryRead more →

Stage IV Non-Small Cell Lung Cancer: Natalie's Patient Story

Patient Info: Natalie, Female, Under 40 | Stage IV

Metastatic Site: Spine

Natalie was living with Stage IV NSCLC after a double lung transplant gave her new lung function, but cancer later appeared in the spine and required renewed chemotherapy and radiation.

The Patient StoryRead more →

Stage I EGFR Lung Cancer: Shira's Survivor Story

Patient Info: Shira, Female | Stage I

Biomarkers: EGFR exon 20 insertion

Shira had Stage IB lung cancer detected early through imaging and treated with surgery alone. Her tumor was later categorized as low risk of recurrence, and she described herself as cancer-free as of February 2026.

The Patient StoryRead more →